PHP

Parkman Healthcare Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 89.76%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+89.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$911M
AUM Growth
+$46.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$17.6M
2
+$15.7M
3
+$14.6M
4
MCK icon
McKesson
MCK
+$7.81M
5
FOLD icon
Amicus Therapeutics
FOLD
+$7.68M

Top Sells

1
+$18.7M
2
+$17.3M
3
+$16.8M
4
RVTY icon
Revvity
RVTY
+$15.2M
5
COO icon
Cooper Companies
COO
+$14.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
76
DELISTED
Dynavax Technologies
DVAX
$2.69M 0.3%
271,306
+1,175
TVRD
77
Tvardi Therapeutics
TVRD
$28.4M
$2.53M 0.28%
+65,000
SLDB icon
78
Solid Biosciences
SLDB
$792M
$2.45M 0.27%
+396,396
DAWN
79
DELISTED
Day One Biopharmaceuticals
DAWN
$2.13M 0.23%
301,746
-198,254
RARE icon
80
Ultragenyx Pharmaceutical
RARE
$2.4B
$2.06M 0.23%
68,636
-79,344
FDMT icon
81
4D Molecular Therapeutics
FDMT
$498M
$1.74M 0.19%
+200,000
QTRX icon
82
Quanterix
QTRX
$152M
$1.37M 0.15%
252,211
-263,781
ANNX icon
83
Annexon
ANNX
$984M
$1.24M 0.14%
405,953
+1,759
BFLY icon
84
Butterfly Network
BFLY
$1.37B
$1.16M 0.13%
+602,192
MASS icon
85
908 Devices
MASS
$253M
$879K 0.1%
100,368
+368
LUNG icon
86
Pulmonx
LUNG
$53.6M
$811K 0.09%
500,662
-104,367
CMPS
87
Compass Pathways
CMPS
$1.3B
$573K 0.06%
+100,000
ENTX icon
88
Entera Bio
ENTX
$62.6M
$539K 0.06%
280,822
-75,000
EDAP
89
EDAP TMS
EDAP
$122M
$355K 0.04%
154,832
OVID icon
90
Ovid Therapeutics
OVID
$459M
$264K 0.03%
+202,978
ALKS icon
91
Alkermes
ALKS
$5.66B
– –
0
ANIP icon
92
ANI Pharmaceuticals
ANIP
$1.81B
– –
-128,478
ARDX icon
93
Ardelyx
ARDX
$1.49B
– –
-301,086
DGX icon
94
Quest Diagnostics
DGX
$21.7B
– –
-40,997
GILD icon
95
Gilead Sciences
GILD
$161B
– –
-131,675
MRUS
96
DELISTED
Merus
MRUS
– –
-162,980
NRIX icon
97
Nurix Therapeutics
NRIX
$1.76B
– –
-228,271
QQQ icon
98
Invesco QQQ Trust
QQQ
$435B
– –
0
REPL icon
99
Replimune Group
REPL
$220M
– –
-896,710
RVTY icon
100
Revvity
RVTY
$9.78B
– –
-157,196
1 2 3
4
5